FDA Unveils Strategies for Non-Addictive Alternatives to Opioids
The U.S. Food and Drug Administration (FDA) this week unveiled new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain and decreasing exposure to opioids and decreasing exposure to opioids. The agenda issued draft guidance to provide recommendations to companies developing non-opioid analgesics for acute pain lasting up to…
Read More »